Bionano stock dips amid launch of Bionano Laboratories for optical genome mapping tests

Sep. 23, 2022 9:07 AM ETBionano Genomics, Inc. (BNGO)By: Ravikash, SA News Editor5 Comments

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research. Working on Computers, Analyzing Samples


  • Bionano Genomics (NASDAQ:BNGO) said it launched Bionano Laboratories, which combines the company's optical genome mapping (OGM) data services with clinical testing services previously offered by Lineagen.
  • The company also launched Bionano Laboratories' first OGM-based laboratory developed test (LDT), according to the Sept. 23 press release.
  • The company added that Bionano Laboratories recently received CLIA-certification for its lab in San Diego.
  • BNGO -3.16% to 3.16% premarket Sept. 23

Recommended For You

Comments (5)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.